Comparison of leishmanin skin test and direct smear for the diagnosis of cutaneous leishmaniasis

Acta Medica Iranica

Volumn 49, Issue 3, 2011, Pages 136-141

  Hashemi, Seyyede Neda ^a   Mohebali, Mehdi ^a   Mansouri, Parvin ^a   Bairami, Amir ^a   Hajjaran, Homa ^a   Akhoundi, Behnaz ^a   Charehdar, Soorour ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutaneous leishmaniasis; Human; Leishmanin skin test; Microscopical examination

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEISHMANIN SKIN TEST; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PARASITE IDENTIFICATION; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SKIN DEFECT; SKIN INDURATION; SKIN LEISHMANIASIS; SMEAR;

ADOLESCENT; ADULT; AGED; ANTIGENS, PROTOZOAN; CHILD; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; SKIN; SKIN TESTS; YOUNG ADULT;

EID: 79958071319     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Momeni AZ, Aminjavaheri M. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol 1994;33(4):260-265.
2. De Luca PM, Mayrink W, Santiago MA, Nogueira R, Conceição-Silva F, Mélo G, Mendonça SC. Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test. Trans R Soc Trop Med Hyg 2003;97(6):709-712.
3. The Iranian Ministry of Health, Treatment and Medical Education, Diseases Management Center. Communicable Diseases, Annual Report, 2003-2005.
4. Osman OF, Kager PA, Oskam L. Leishmaniasis in the Sudan: a literature review with emphasis on clinical aspects. Trop Med Int Health 2000;5(8):553-562.
5. Weigle KA, Valderrama L, Arias AL, Santrich C, Saravia NG. Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am J Trop Med Hyg 1991;44(3):260-271.
6. Dowlati Y. Cutaneous leishmaniasis: clinical aspect. Clin Dermatol 1996;14(5):425-431.
7. De Rossell RA, Bray RS, Alexander J. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunol 1987;9(1):105-115.
8. Arana BA, Roca M, Rizzo NR, Mendoza CE, Kroeger A. Evaluation of a standardized leishmanin skin test in Guatemala. Trans R Soc Trop Med Hyg 1999;93(4):394-396.
9. Pampiglione S, Manson-Bahr PE, La Placa M, Borgatti MA, Micheloni F. Studies on Mediterranean leishmaniasis. IV. The leishmanin skin test in cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1976;70(1):62-65.
10. Faber WR, Oskam L, van Gool T, Kroon NC, Knegt-Junk KJ, Hofwegen H, van der Wal AC, Kager PA. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003;49(1):70-74.
11. Sokal JE. Editorial: Measurement of delayed skin-test responses. N Engl J Med 1975;293(10):501-502.
12. Weigle KA, Escobar M, Arias AL, Martinez F, Rojas C. A clinical prediction rule for American cutaneous leishmaniasis in Colombia. Int J Epidemiol 1993;22(3):548-558.